Related Experiment Video
Updated: Nov 4, 2025

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry
Published on: September 27, 2020
Neuroinflammation as a Therapeutic Target for Mitigating the Long-Term Consequences of Acute Organophosphate
Peter M Andrew1, Pamela J Lein1
1Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, United States.
Abstract:
Acute intoxication with organophosphates (OPs) can cause a potentially fatal cholinergic crisis characterized by peripheral parasympathomimetic symptoms and seizures that rapidly progress to status epilepticus (SE). While current therapeutic countermeasures for acute OP intoxication significantly improve the chances of survival when administered promptly, they are insufficient for protecting individuals from chronic neurologic outcomes such as cognitive deficits, affective disorders, and acquired epilepsy. Neuroinflammation is posited to contribute to the pathogenesis of these long-term neurologic sequelae. In this review, we summarize what is currently known regarding the progression of neuroinflammatory responses after acute OP intoxication, drawing parallels to other models of SE. We also discuss studies in which neuroinflammation was targeted following OP-induced SE, and explain possible reasons why such therapeutic interventions have inconsistently and only partially improved long-term outcomes. Finally, we suggest future directions for the development of therapeutic strategies that target neuroinflammation to mitigate the neurologic sequelae of acute OP intoxication.
Insights
Organophosphate (OP) poisoning causes seizures and severe outcomes. Targeting neuroinflammation after OP-induced status epilepticus (SE) may prevent chronic neurological damage, but current strategies show inconsistent results.
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- Acute organophosphate (OP) intoxication can lead to a cholinergic crisis, seizures, and status epilepticus (SE).
- Current treatments improve survival but fail to prevent chronic neurological deficits like cognitive impairment and epilepsy.
- Neuroinflammation is implicated in the long-term neurological damage following OP exposure.
Purpose of the Study:
- To review the progression of neuroinflammation after acute OP intoxication and SE.
- To examine therapeutic strategies targeting neuroinflammation in OP-induced SE.
- To identify reasons for inconsistent outcomes and suggest future research directions.
Main Methods:
- Literature review summarizing existing research on OP intoxication, SE, and neuroinflammation.
- Comparative analysis of neuroinflammatory responses in OP-induced SE and other SE models.
- Discussion of studies investigating anti-neuroinflammatory treatments post-OP-induced SE.
Main Results:
- Neuroinflammation is a key factor in the chronic neurological sequelae of OP intoxication.
- Targeting neuroinflammation has shown inconsistent and only partial efficacy in mitigating long-term outcomes.
- The timing and specific pathways of neuroinflammation likely influence therapeutic effectiveness.
Conclusions:
- Neuroinflammation plays a critical role in the chronic neurological damage following organophosphate poisoning.
- Current therapeutic interventions targeting neuroinflammation are insufficient for complete neuroprotection.
- Future strategies should focus on precisely timed and pathway-specific neuroinflammation modulation for better outcomes.
More Related Videos
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Prevention of Further Absorption of Poison
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...

